Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine.
Chadi G AbdallahGraeme F MasonPublished in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2022)